日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Impact of COVID-19 on new pharmacotherapy for insomnia: A matched cohort study using the national insurance claims database in Japan

COVID-19 对失眠新药治疗的影响：一项基于日本国家医疗保险索赔数据库的匹配队列研究

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0341416
Miyamori, Daisuke; Yoshida, Shuhei; Omori, Wataru; Kashima, Saori; Ito, Masanori
发表日期：2026
文献求助 收藏

Impact of COVID-19 on antidepressant prescription: a matched cohort study using the National insurance claims database in Japan

COVID-19 对抗抑郁药处方的影响：一项基于日本国家医疗保险索赔数据库的匹配队列研究

期刊:BMC Psychiatry
影响因子:3.6
doi:10.1186/s12888-025-07172-w
Miyamori, Daisuke; Yoshida, Shuhei; Omori, Wataru; Kashima, Saori; Ito, Masanori
神经科学
发表日期：2025
文献求助 收藏

Approaches for difficult-to-induce-seizures electroconvulsive therapy cases (DEC): a Japanese expert consensus

难诱发癫痫的电休克治疗（DEC）病例的处理方法：日本专家共识

期刊:Annals of General Psychiatry
影响因子:3.1
doi:10.1186/s12991-024-00543-9
Takekita, Yoshiteru; Suwa, Taro; Yasuda, Kazuyuki; Kawashima, Hirotsugu; Omori, Wataru; Kurimoto, Naoki; Tsuboi, Takashi; Noda, Takamasa; Aoki, Nobuatsu; Wada, Ken; Inada, Ken; Takebayash, Minoru
癫痫
神经科学
发表日期：2025
文献求助 收藏

Personalized Prediction of Clozapine Treatment Response Using Therapeutic Drug Monitoring Data in Japanese Patients with Treatment-Resistant Schizophrenia

利用治疗药物监测数据对日本难治性精神分裂症患者氯氮平治疗反应进行个性化预测

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14217892
Nakahara, Tatsuo; Harada, Yukiko; Nakayama, Naho; Hashimoto, Kijiro; Kida, Naoya; Onitsuka, Toshiaki; Noda, Hiroo; Murasugi, Kenji; Takimoto, Yoshihiro; Omori, Wataru; Sukegawa, Tsuruhei; Shiraishi, Jun; Tanaka, Kouji; Maesato, Hitoshi; Ueno, Takefumi
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Role of regular medical visits in mitigating increased suicide risk during the early COVID-19 pandemic in Kobe, Japan

在日本神户，定期就医在降低新冠疫情早期自杀风险方面所起的作用

期刊:BMC Primary Care
影响因子:2.6
doi:10.1186/s12875-025-02707-2
Miyamori, Daisuke; Nagasaki, Yasushi; Yoshida, Shuhei; Kashima, Saori; Omori, Wataru; Itagaki, Kei; Ito, Masanori
微生物学
新冠
发表日期：2025
文献求助 收藏

Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy.

接受电休克疗法治疗的抑郁症患者血清中高迁移率族蛋白-1 (HMGB1) 和晚期糖基化终产物可溶性受体 (RAGE) 的水平

期刊:Neuropsychopharmacology Reports
影响因子:1.5
doi:10.1002/npr2.12358
Abe Hiromi, Okada-Tsuchioka Mami, Kajitani Naoto, Omori Wataru, Itagaki Kei, Shibasaki Chiyo, Boku Shuken, Matsuhisa Tetsuaki, Takebayashi Minoru
神经科学
抑郁症
HMGB1
发表日期：2023
文献求助 收藏

Increased matrix metalloproteinases in cerebrospinal fluids of patients with major depressive disorder and schizophrenia

重度抑郁症和精神分裂症患者脑脊液中基质金属蛋白酶水平升高

期刊:International Journal of Neuropsychopharmacology
影响因子:3.7
doi:10.1093/ijnp/pyaa049
Omori, Wataru; Hattori, Kotaro; Kajitani, Naoto; Tsuchioka, Mami Okada-; Boku, Shuken; Kunugi, Hiroshi; Okamoto, Yasumasa; Takebayashi, Minoru
精神分裂症
抑郁症
神经科学
发表日期：2020
文献求助 收藏

Decreased serum levels of thrombospondin-1 in female depressed patients.

女性抑郁症患者血清中血小板反应蛋白-1水平降低

期刊:Neuropsychopharmacology Reports
影响因子:1.5
doi:10.1002/npr2.12088
Okada-Tsuchioka Mami, Omori Wataru, Kajitani Naoto, Shibasaki Chiyo, Itagaki Kei, Takebayashi Minoru
神经科学
抑郁症
发表日期：2020
文献求助 收藏

Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders

四种主要精神疾病患者在接受电休克治疗后复发的共同预防因素

期刊:Psychiatry and Clinical Neurosciences
影响因子:6.2
doi:10.1111/pcn.12859
Omori, Wataru; Itagaki, Kei; Kajitani, Naoto; Abe, Hiromi; Okada-Tsuchioka, Mami; Okamoto, Yasumasa; Takebayashi, Minoru
发表日期：2019
文献求助 收藏